Selective agents for pain suppression
USRE47475E1 · kind E1 · reissue
Assignee
Inventors
Key dates
| Filing date | Sep 16, 2016 |
| Grant date | Jul 2, 2019 |
| Priority date | — |
| Expiry date | Sep 16, 2036 |
Classification
- Technology area (CPC —)General
Abstract
In preferred embodiments, the present invention provides methods of treatment and pharmaceutical compositions for the suppression, alleviation and prevention of the often chronic, severe and debilitating pain that can accompany inflammatory diseases and neuropathic insults, pain that is often unresponsive to conventional analgesic treatment. The preferred embodiments of the present invention further relate to methods of treatment and pharmaceutical compositions using benzodiazepine derivatives that provide suppression, alleviation and prevention of neuropathic pain, migraine-related pain and inflammatory pain with reduced sedative and ataxic side effects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.